Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

A class of type-2 Schloegl models is considered for particles on a square lattice with variable-range cooperativity. These models involve: (i) spontaneous particle annihilation at rate p; (ii) autocatalytic particle creation at unoccupied sites (i, j) with n≥2 particles within a specified neighborhood, Ω_{N}(i,j), of N sites at rate k_{n}=(n/2)/(N/2)=n(n-1)/N(N-1); and (iii) possible spontaneous particle creation at unoccupied sites at "small" rate ɛ≥0. In some cases, Ω_{N} just includes all symmetry-equivalent sites at a single specific distance d (in units of lattice constants) from the unoccupied site, e.g., d=1 (nearest-neighbor sites) where N=4, or d=√5 (or √13 or…) where N=8. In other cases, Ω_{N} includes sites multiple distances from the unoccupied site, e.g., d={1,√2}, where N=8. Kinetic Monte Carlo (KMC) simulation reveals that these models exhibit a nonequilibrium discontinuous phase transition between high- and low-density states below a critical point, ɛ<ɛ_{c}, with generic two-phase coexistence (2PC) at least for smaller N. With some exceptions, there is an approach toward mean-field behavior with increasing N (so the regime of generic 2PC shrinks, and ɛ_{c} approaches the mean-field value of 1/27). Additional insight into trends is provided by analysis of the exact master equations for the models via hierarchical truncation. These truncations utilize suitably tailored pair approximations which reflect the dominant nonequilibrium spatial correlations. These correlations in turn are shown to reflect the details of the autocatalytic particle creation process. For spatially heterogeneous states, the truncations produce coupled sets of lattice differential equations (LDE) which can describe orientation-dependent propagation of an interface between high- and low-density steady states for ɛ<ɛ_{c}. Pair approximation values of p=p_{eq} where the interface is stationary, and its orientation-dependence, are in semiquantitative agreement with KMC results. This comparison accounts for propagation failure in the LDE which complicates interpretation.

Download full-text PDF

Source
http://dx.doi.org/10.1103/y54y-5dvxDOI Listing

Publication Analysis

Top Keywords

class type-2
8
type-2 schloegl
8
schloegl models
8
spontaneous particle
8
particle creation
8
creation unoccupied
8
unoccupied sites
8
cases Ω_{n}
8
Ω_{n} includes
8
unoccupied site
8

Similar Publications

Introduction: This study examines the characteristics of adults with type 2 diabetes (T2D) who were not initially treated with an antihyperglycemic agent (AHA).

Methods: The analyses used Optum de-identified Market Clarity data from January 2013 through September 2023. The US study included nonpregnant adults with T2D who were continuously insured from 1 year prior through 5 years post diagnosis and did not fill a prescription for an AHA in the year after their initial T2D diagnosis.

View Article and Find Full Text PDF

Introduction: Frequent glycated hemoglobin A1c (HbA1c) monitoring is recommended in individuals with type 2 diabetes mellitus (T2D). We aimed to identify distinct, long-term HbA1c trajectories following a T2D diagnosis and investigate how these glycemic control trajectories were associated with health-related traits and T2D complications.

Research Design And Methods: A cohort of 12,435 unrelated individuals of European ancestry with T2D was extracted from the UK Biobank data linked to primary care records.

View Article and Find Full Text PDF

Metabolomics Insights into the Benefits of SGLT2 Inhibitors in Type 2 Diabetes.

Clin Pharmacol

August 2025

Division of Endocrinology and Metabolism and Diabetes Center, First Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, Greece.

Background: Sodium-glucose cotransporter 2 (SGLT2) inhibitors are an established class of agents in the treatment of type 2 diabetes mellitus (T2DM), with proven cardiovascular and renal benefits. However, their precise mechanisms of action remain incompletely understood. Metabolomics offers a powerful approach to uncovering drug-induced alterations in metabolic pathways.

View Article and Find Full Text PDF

Established and Emerging Therapies for Cardiovascular-Kidney-Metabolic Syndrome: Harnessing the Benefits of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and Beyond.

Heart Lung Circ

September 2025

Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia; Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia; Department of Cardiology, Central Adelaide Local Health Network, Adelaide, SA,

Cardiovascular-kidney-metabolic (CKM) syndrome is a term that is increasingly used to describe interconnected conditions that lead to poor health outcomes, including cardiovascular disease, chronic kidney disease, type 2 diabetes, and obesity. Historically, there have been very few targeted pharmacotherapies available that have changed cardiovascular outcomes for people with CKM syndromes; however, over the past decade, new pharmacologic options have rapidly expanded, with strong evidence for cardiovascular and kidney protective benefits in CKM conditions. Of note, sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists have emerged as key therapeutic options and are now widely guideline-endorsed.

View Article and Find Full Text PDF

Increased Cholesterol Interactions in the Active Conformational State of the Glucagon-Like Peptide-1 Receptor.

Biophys J

September 2025

CSIR-National Chemical Laboratory, Dr. Homi Bhabha Road, Pune 411 008, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201 002, India. Electronic address:

The glucagon-like peptide-1 receptor (GLP-1R) is a class B G protein-coupled receptor (GPCR) that plays an important role in metabolic regulation, and consequently is a target for type 2 diabetes and obesity therapeutics. Although cholesterol has been reported to be implicated in receptor activation, its interactions with the receptor during the activation cycle have not been probed. Using coarse-grained molecular dynamics simulations, we have characterized the cholesterol interactions with GLP-1R in four conformational states: the inactive, partially active, GLP-1-bound active, and exenatide-bound active conformational states.

View Article and Find Full Text PDF